These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15200468)
1. Development of malignancy after treatment of idiopathic membranous nephropathy. Lai MY; Yang WC; Lin CC Kidney Int; 2004 Jul; 66(1):464; author reply 464-5. PubMed ID: 15200468 [No Abstract] [Full Text] [Related]
3. Efficacy of immunosuppressive treatment in patients with membranous nephropathy and renal insufficiency. Wetzels JF; Reichert LJ Kidney Int Suppl; 1997 Oct; 61():S63-6. PubMed ID: 9328969 [No Abstract] [Full Text] [Related]
4. Mycophenolate mofetil in treatment of idiopathic stages III-IV membranous nephropathy. Polenakovic M; Grcevska L; Dzikova S Nephrol Dial Transplant; 2003 Jun; 18(6):1233-4. PubMed ID: 12748370 [No Abstract] [Full Text] [Related]
5. Therapy of membranous nephropathy with severe azotemia. Prabhakar S; Kahn T Clin Nephrol; 1996 Jun; 45(6):419. PubMed ID: 8793240 [No Abstract] [Full Text] [Related]
6. Treatment of progressive renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone. Baker LR; Tucker B; Macdougall IC; Oommen R Nephrol Dial Transplant; 1998 Oct; 13(10):2704. PubMed ID: 9794596 [No Abstract] [Full Text] [Related]
7. An overview of immunosuppressive therapy in idiopathic membranous nephropathy. Maas R; Hofstra JM; Wetzels JF Minerva Med; 2012 Aug; 103(4):253-66. PubMed ID: 22805618 [TBL] [Abstract][Full Text] [Related]
8. Membranous glomerulonephritis, psoriasis and etanercept. A chance or causal association? Florit EA; Ubeda-Aranda I; Delgado-Conde P; Rodríguez-Cubillo B; Monzón-Vázquez T; de la Flor Merino JC; Valga-Amado F; Barrientos-Guzmán A Nefrologia; 2012; 32(2):228-32. PubMed ID: 22421953 [TBL] [Abstract][Full Text] [Related]
9. The treatment of idiopathic membranous nephropathy: a dilemma or a conundrum? Glassock RJ Am J Kidney Dis; 2004 Sep; 44(3):562-6. PubMed ID: 15332231 [No Abstract] [Full Text] [Related]
10. A difficult trade off for adults with membranous nephropathy. BMJ; 2013 Jan; 346():f248. PubMed ID: 23325868 [No Abstract] [Full Text] [Related]
11. Balancing cancer risk and efficacy of using cyclophosphamide to treat idiopathic membranous nephropathy. Khan S; Bolton WK Clin J Am Soc Nephrol; 2014 Jun; 9(6):1001-4. PubMed ID: 24855281 [No Abstract] [Full Text] [Related]
12. Does cyclosporin have a role in the treatment of membranous nephropathy? Ponticelli C; Villa M Nephrol Dial Transplant; 1999 Jan; 14(1):23-5. PubMed ID: 10052467 [No Abstract] [Full Text] [Related]
13. Effective treatment of Kaposi sarcoma with everolimus in a patient with membranous glomerulonephritis. Rukasz D; Krajewska M; Augustyniak-Bartosik H; Letachowicz K; Hałoń A; Ekiert M; Jakuszko K; Madziarska K; Weyde W; Klinger M Intern Med J; 2015 Feb; 45(2):230-1. PubMed ID: 25650540 [No Abstract] [Full Text] [Related]
14. Idiopathic membranous nephropathy: diagnosis and treatment. Fervenza FC; Sethi S; Specks U Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148 [TBL] [Abstract][Full Text] [Related]
15. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy. du Buf-Vereijken PW; Branten AJ; Wetzels JF Am J Kidney Dis; 2005 Dec; 46(6):1012-29. PubMed ID: 16310567 [TBL] [Abstract][Full Text] [Related]
16. [Immunosuppression in membranous glomerulonephritis - contra]. Wüthrich RP Dtsch Med Wochenschr; 2009 Aug; 134(34-35):1687. PubMed ID: 19707966 [No Abstract] [Full Text] [Related]